S. Y. Tung

Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma--correlation with excision repair cross-complementing-1 polymorphisms (2009)

Ma, B. B. Y., Hui, E. P., Wong, S. C. C., Tung, S. Y., Yuen, K. K., King, A., ...

Background: Nasopharyngeal carcinoma (NPC) is a platinum-sensitive cancer and excision repair cross-complementing group 1 (ERCC1) polymorphisms have been shown to predict survival in several cancers...